Exploring Frequency Band-Based Biomarkers of EEG Signals for Mild Cognitive Impairment Detection

Insights

A new framework identifies key EEG frequency sub-bands for Mild Cognitive Impairment (MCI) detection. The 16-32 Hz range showed the most impact, improving diagnostic accuracy for early dementia detection.

Area of Science:

  • Neuroscience
  • Biomedical Engineering
  • Data Science

Background:

  • Mild Cognitive Impairment (MCI) is a precursor to Alzheimer's disease (AD), necessitating early detection for intervention.
  • Electroencephalography (EEG) is vital for identifying MCI biomarkers, but precise frequency band analysis remains challenging.
  • Existing methods struggle to pinpoint specific EEG frequency sub-bands crucial for accurate MCI diagnosis.

Purpose of the Study:

  • To develop a novel framework for identifying critical frequency sub-bands in EEG signals for improved MCI detection.
  • To evaluate the diagnostic utility of different EEG frequency sub-bands and compare them to full-band analysis.
  • To enhance the accuracy of MCI detection using advanced signal processing and machine learning techniques.

Main Methods:

  • EEG signals were denoised using stationary wavelet transformation and segmented.
  • Spectrogram images were generated for four extracted frequency sub-bands and the full band.
  • A convolutional neural network (CNN) was individually applied to each set of spectrogram images for classification.

Main Results:

  • The 16-32 Hz EEG sub-band demonstrated the most significant impact on MCI detection.
  • The 4-8 Hz sub-band also showed considerable importance in identifying MCI.
  • The proposed framework utilizing the full frequency band outperformed current state-of-the-art methods.

Conclusions:

  • The 16-32 Hz and 4-8 Hz frequency sub-bands are critical biomarkers for MCI detection via EEG.
  • The novel framework offers a promising approach for developing advanced diagnostic tools for MCI and dementia.
  • This method advances the field of neurophysiological diagnostics for cognitive decline.